Evidence map›Paper›PMID 37775976›Full record

ArticleClinical and translational science2023

Serum HMGB1 is a biomarker for acute myocardial infarction with or without heart failure.

Abdul Wahid, Juan Wen, Qiong Yang, Zhihui Zhang, Xiexiong Zhao, Xiaohong Tang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. TIM-3 in Cardiovascular Disease.Current heart failure reports · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. NF-Frontiers in cardiovascular medicine · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Expression ofGenes · 2024
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Abdul WahidDepartment of Cardiology of the Third Xiang-Ya Hospital, Central South University, Changsha, Hunan, China.
Juan WenDepartment of Cardiology of the Third Xiang-Ya Hospital, Central South University, Changsha, Hunan, China.
Qiong YangDepartment of Cardiology of the Third Xiang-Ya Hospital, Central South University, Changsha, Hunan, China.
Zhihui ZhangDepartment of Cardiology of the Third Xiang-Ya Hospital, Central South University, Changsha, Hunan, China.
Xiexiong ZhaoDepartment of Cardiology of the Third Xiang-Ya Hospital, Central South University, Changsha, Hunan, China.ORCID 0000-0002-2570-7390
Xiaohong TangDepartment of Cardiology of the Third Xiang-Ya Hospital, Central South University, Changsha, Hunan, China.
Central South University · CN

Funding

National Natural Science Foundation of Hunan 2020JJ4850
6 · The paper itself

Abstract

This study measured serum high mobility group box 1 (HMGB1) levels in patients with acute myocardial infarction (AMI) and/or heart failure (HF) and evaluated their relationship with peripheral inflammatory biomarkers and cardiac biomarkers, which have not been reported before. Of the patients, 55 had AMI without HF (AMI

Indexed as

Heart FailureHMGB1 ProteinMyocardial InfarctionBiomarkersHumansStroke VolumeUric AcidVentricular Function, LeftBiomarkersHMGB1 ProteinHMGB1 protein, humanUric Acid

Identifiers

PMID37775976
PMCPMC10651663
OpenAlexW4387210186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.